• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT HAVAB IGM; IGM ANTI-HAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT HAVAB IGM; IGM ANTI-HAV Back to Search Results
Catalog Number 06C30-27
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/23/2017
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 6c30 that has a similar product distributed in the us, list number 6l21.
 
Event Description
The customer obtained (b)(6) architect havab-igm results from one patient while testing it multiple times.(b)(6) generated two (b)(6) results (b)(6) and generated multiple (b)(6) results ranging from (b)(6).The sample also generated (b)(6) results on a second reagent lot.No specific patient information was provided.No adverse impact to patient management was reported.
 
Manufacturer Narrative
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, in-house testing and a review of labeling.Ticket searches determined that there is normal complaint activity for the likely cause lot number.Tracking and trending report review for the architect havab-igm assay determined that there are no related non-statistical or adverse trends.The clinical sensitivity of reagent lot 77622li00 was evaluated by testing one commercially available seroconversion panel.The seroconversion panel results were compared with historical architect havab igm data provided by the panel manufacturer.The complaint lot detected the same first bleed as (b)(6) with comparable (b)(6) values.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.Based on the available information, no systemic issue or deficiency of the architect havab-igm assay was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB IGM
Type of Device
IGM ANTI-HAV
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key7014786
MDR Text Key92659251
Report Number3002809144-2017-00147
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/08/2018
Device Catalogue Number06C30-27
Device Lot Number77622LI00
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 10/23/2017
Initial Date FDA Received11/09/2017
Supplement Dates Manufacturer Received01/30/2018
Supplement Dates FDA Received01/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; LIST 03M74-01, SERIAL (B)(4); LIST 03M74-01, SERIAL (B)(4)
-
-